GEKTERNA:ATHEXGek Terna S.A. Analysis
Data as of 2026-03-15 - not real-time
€34.92
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Technical outlook is mixed but leans bullish: the short‑term moving average sits above the medium‑term average, reinforcing a bullish trend, while the MACD histogram is negative and the signal line is bearish, suggesting short‑term pressure. RSI hovers around the neutral zone and volume is increasing, indicating growing participation. The price is comfortably above the identified support level and below resistance, giving the stock room to move higher amid a market sentiment classified as “Greed.”
Fundamentals raise red flags: the company carries an extremely high debt‑to‑equity ratio and reports zero operating cash flow, while revenue is contracting. Valuation metrics are divergent – an astronomically high trailing P/E contrasts with a reasonable forward P/E, and the price‑to‑sales ratio is below one. Dividend yield is modest and the payout ratio, though low, rests on fragile earnings, making sustainability questionable despite a strong analyst consensus and a modest upside target.
Fundamentals raise red flags: the company carries an extremely high debt‑to‑equity ratio and reports zero operating cash flow, while revenue is contracting. Valuation metrics are divergent – an astronomically high trailing P/E contrasts with a reasonable forward P/E, and the price‑to‑sales ratio is below one. Dividend yield is modest and the payout ratio, though low, rests on fragile earnings, making sustainability questionable despite a strong analyst consensus and a modest upside target.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bullish SMA crossover supporting short‑term momentum
- Bearish MACD histogram indicating near‑term downside risk
- Elevated 30‑day volatility increasing price swing potential
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Forward earnings estimate suggests a strong earnings rebound
- Analyst consensus of strong‑buy and target price above current level
- Support level provides downside protection while trend remains bullish
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- High leverage and zero operating cash flow constrain financial flexibility
- Diversified project portfolio across regions offers growth upside
- Modest dividend yield with low payout ratio but uncertain sustainability
Key Metrics & Analysis
Financial Health
Revenue Growth-5.40%
Profit Margin21.30%
P/E Ratio1164.0
Debt/Equity245.99
P/B Ratio1.9
Industry P/E29.1
Technical Analysis
TrendBullish
RSI54.7
Support€31.20
Resistance€36.72
MA 20€34.82
MA 50€32.48
MA 200€24.88
MACDBearish
VolumeIncreasing
Fear & Greed Index72.88
Valuation
Target Price€38.29
Upside/Downside9.64%
GradeOvervalued
TypeBlend
Dividend Yield1.18%
Risk Assessment
Beta0.34
Volatility42.32%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.